Literature DB >> 23548152

Experimental induction and oral transmission of avian AA amyloidosis in vaccinated white hens.

Tomoaki Murakami1, Naeem Muhammad, Yasuo Inoshima, Tokuma Yanai, Masanobu Goryo, Naotaka Ishiguro.   

Abstract

Avian AA amyloidosis is commonly observed in adult birds afflicted with bacterial infections or chronic inflammatory disorders. Experimental AA amyloidosis in birds can be induced by repeated inflammatory stimulation, such as injection with casein or vaccination with oil-emulsified bacterins. However, the transmission of amyloidosis among avian species has not been studied well to date. In the present study, we confirm the potential induction of avian AA amyloidosis by inoculation of Salmonella enteritidis (SE) vaccine or Mycoplasma gallisepticum vaccine. To determine the transmission of chicken AA amyloidosis among white hens, we induced experimental AA amyloidosis in vaccinated chickens by intravenous or oral administration of chicken AA fibrils. Amyloid deposits were observed in chickens injected with SE and inoculated with chicken AA fibrils intravenously (21/26: 81%) and orally (8/12: 67%). These results suggest that chicken AA amyloidosis can be induced by vaccinations, and may be transmitted among like species by oral administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548152     DOI: 10.3109/13506129.2013.783474

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  9 in total

Review 1.  Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.

Authors:  Gunilla T Westermark; Marcus Fändrich; Katarzyna Lundmark; Per Westermark
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  Amyloidosis in a Captive Zebra Finch (Taeniopygia guttata) Research Colony.

Authors:  Lisa J Shientag; David S Garlick; Erin Galati
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

3.  Species-barrier on the cross-species oral transmission of bovine AA amyloidosis in mice.

Authors:  Susumu Iwaide; Naoki Ujike; Kyoko Kobayashi; Yukiko Sassa; Tomoaki Murakami
Journal:  J Vet Med Sci       Date:  2021-04-28       Impact factor: 1.267

4.  Prevalence of amyloid deposition in mature healthy chickens in the flock that previously had outbreaks of vaccine-associated amyloidosis.

Authors:  Kanata Ibi; Tomoaki Murakami; Wael Mohamed Goda; Naoki Kobayashi; Naotaka Ishiguro; Tokuma Yanai
Journal:  J Vet Med Sci       Date:  2015-05-18       Impact factor: 1.267

5.  Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes.

Authors:  Patricia M Gaffney; Denise M Imai; Deana L Clifford; Majid Ghassemian; Roman Sasik; Aaron N Chang; Timothy D O'Brien; Judith Coppinger; Margarita Trejo; Eliezer Masliah; Linda Munson; Christina Sigurdson
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

6.  Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice.

Authors:  Mayuko Maeda; Tomoaki Murakami; Naeem Muhammad; Yasuo Inoshima; Naotaka Ishiguro
Journal:  Exp Anim       Date:  2016-06-16

7.  Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus).

Authors:  Désirée S Jansson; Caroline Bröjer; Aleksija Neimanis; Torsten Mörner; Charles L Murphy; Faruk Otman; Per Westermark
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

8.  Oxazolone-induced gastrointestinal disorders enhance the oral transmission of AA amyloidosis in mice.

Authors:  Hiroto Kobayashi; Susumu Iwaide; Naoki Ujike; Tomoaki Murakami
Journal:  J Vet Med Sci       Date:  2021-04-20       Impact factor: 1.267

9.  Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.

Authors:  Mu Yang; Yingye Liu; Jian Dai; Lin Li; Xin Ding; Zhe Xu; Masayuki Mori; Hiroki Miyahara; Jinko Sawashita; Keiichi Higuchi
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.